WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 206164
CAS#: M2698 HCl
Description: MSC2363318A, also known as M2698, is an orally available inhibitor of the serine/threonine protein kinases ribosomal protein S6 Kinase (p70S6K) and Akt (protein kinase B), with potential antineoplastic activity. Upon administration, p70S6K/Akt inhibitor MSC2363318A binds to and inhibits the activity of p70S6K and Akt. This prevents the activation of the PI3K/Akt/p70S6K signaling pathway and inhibits tumor cell proliferation in cancer cells that have an overactivated PI3K/Akt/p70S6K signaling pathway. Constitutive activation and dysregulated signaling of the PI3K/Akt/p70S6K pathway are frequently associated with tumorigenesis of many tumor types; targeting multiple kinases in this pathway is more efficacious than targeting a single kinase.
MedKoo Cat#: 206164
Name: M2698 HCl
CAS#: M2698 HCl
Chemical Formula: C21H20Cl2F3N5O
Exact Mass:
Molecular Weight: 486.3202
Elemental Analysis: C, 51.87; H, 4.15; Cl, 14.58; F, 11.72; N, 14.40; O, 3.29
Related CAS #: 1379545-95-5 (free base) M2698 HCl
Synonym: M2698 HCl; M2698 Hhydrochloride; MSC2363318A; MSC 2363318A; MSC-2363318A; M2698; M-2698; M 2698.
IUPAC/Chemical Name: (S)-4-((2-(azetidin-1-yl)-1-(4-chloro-3-(trifluoromethyl)phenyl)ethyl)amino)quinazoline-8-carboxamide hydrochloride
InChi Key: AVLBEMHEKRLPQR-UNTBIKODSA-N
InChi Code: InChI=1S/C21H19ClF3N5O.ClH/c22-16-6-5-12(9-15(16)21(23,24)25)17(10-30-7-2-8-30)29-20-14-4-1-3-13(19(26)31)18(14)27-11-28-20;/h1,3-6,9,11,17H,2,7-8,10H2,(H2,26,31)(H,27,28,29);1H/t17-;/m1./s1
SMILES Code: O=C(C1=CC=CC2=C(N[C@@H](C3=CC=C(Cl)C(C(F)(F)F)=C3)CN4CCC4)N=CN=C12)N.[H]Cl
